Status:
RECRUITING
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
Roche Sequencing Solutions
The Foundation for Barnes-Jewish Hospital
Conditions:
Healthy Volunteer
Prostate Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Earlier detection of disease recurrence will enable greater treatment options and has strong potential to improve patient outcomes. This project is translational and has the potential to lead to futur...
Eligibility Criteria
Inclusion
- Eligible healthy donors will be at least 18 years of age.
Exclusion
- Healthy donors younger than 18 years of age
Key Trial Info
Start Date :
May 29 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04354064
Start Date
May 29 2019
End Date
December 31 2025
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110